Cargando…
Anticoagulant Therapy in Initially Low‐Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors
BACKGROUND: The CHA(2)DS(2)‐VASc score has been validated for stroke risk prediction in patients with atrial fibrillation (AF). Antithrombotic therapy is not recommended for low‐risk patients with AF (CHA(2)DS(2)‐VASc 0 [male] or 1 [female]). We studied a cohort of initially low‐risk patients with A...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660835/ https://www.ncbi.nlm.nih.gov/pubmed/32779499 http://dx.doi.org/10.1161/JAHA.120.016271 |